NASDAQ:PACB

Pacific Biosciences Of California Stock News

Healthcare > Medical - Devices

Buy PACB

*Your capital is at risk

$1.45

-0.180 (-11.04%)

At Close: Jun 05, 2026

Investors Are Invited To Help The Schall Law Firm Look Into Pacific Biosciences of California Inc For Possible Securities Fraud

11:00am, Thursday, 26'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California, Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation

11:00am, Wednesday, 25'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

The Schall Law Firm Has Launched An Inquiry Into Pacific Biosciences of California Inc's Possible Securities Fraud And Impacted Investors Are Invited To Reach Out

11:00am, Tuesday, 24'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California, Inc. Is Being Looked Into For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation

11:00am, Monday, 23'rd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Investors Are Invited By The Schall Law Firm To Help Investigate Pacific Biosciences of California Inc's Possible Securities Fraud

11:00am, Sunday, 22'nd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California, Inc. May Have Violated Securities Laws And The Schall Law Firm Wants Shareholders To Join An Inquiry

11:00am, Saturday, 21'st Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

The Schall Law Firm Is Looking Into Pacific Biosciences of California Inc For Possible Securities Fraud And Affected Investors Are Urged To Reach Out

11:00am, Friday, 20'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California, Inc. May Have Violated Securities Laws And Stockholders Can Help The Schall Law Firm Investigate

11:00am, Thursday, 19'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

The Schall Law Firm Invites Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

11:00am, Wednesday, 18'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California, Inc. Is Being Investigated For Securities Related Infractions And Shareholders Are Urged To Contact The Schall Law Firm

11:00am, Tuesday, 17'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

The Schall Law Firm Is Looking Into Pacific Biosciences of California Inc For Possible Securities Fraud And Investors Should Participate

11:00am, Monday, 16'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences Of California, Inc. May Have Violated Securities Laws And Shareholders Are Invited By The Schall Law Firm To Join An Investigation

11:00am, Sunday, 15'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

The Schall Law Firm Requests Investor Participation In An Inquiry Into Pacific Biosciences Of California Inc For Possible Securities Fraud

11:00am, Saturday, 14'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Pacific Biosciences of California (PACB) Surpasses Market Returns: Some Facts Worth Knowing

07:18pm, Friday, 13'th Sep 2024

Pacific Biosciences of California (PACB) closed at $1.81 in the latest trading session, marking a +0.56% move from the prior day.

Pacific Biosciences Of California, Inc. May Have Violated Securities Regulations And Affected Shareholders Can Help The Schall Law Firm Investigate

11:00am, Friday, 13'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by